Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1529
Journal of Infectious Diseases & Therapy received 1529 citations as per Google Scholar report
Indexed In
- Index Copernicus
- Google Scholar
- Open J Gate
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production
2nd International Conference on Influenza
Parvaneh Mehrbod, Asghar Abdoli, Hoorieh Soleimanjahi, Abbas Jamali, Shima Gholami, Zahra Kianmehr, Neda Feizi, Maryam Saleh, Fariborz Bahrami, Talat Mokhtari-Azad, Mohsen Abdoli and Masoumeh Tavassoti Kheiri
Pasteur Institute of Iran, Iran Tarbiat Modares University, Iran Shahed University, Iran Tehran University of Medical Sciences, Iran
Posters & Accepted Abstracts: J Infect Dis Ther
Abstract
Increasing demands for seasonal influenza vaccine and the need for faster methods of vaccine production during flu pandemics and the threat posed by highly pathogenic avian influenza viruses, have made cell culture a suitable substrate for influenza vaccine manufacturers. Cell-adapted viruses replicate with high fidelity, which are expected to have potent vaccine immunogenicity. The aim of this study was evaluating MDCK and MDCK-SIAT1 cell lines for their ability to produce the yield of influenza virus. Yields obtained for influenza virus H1N1 grown in MDCK-SIAT1 cell was almost the same level as MDCK; however, H3N2 virus grown in MDCK-SIAT1 showed lower peak of viral titers in comparison with MDCK cells. The optimized MOI to infect the cells on plates and microcarrier was 0.01 and 0.1 for H1N1 and 0.001 and 0.01 for H3N2, respectively. MDCK-SIAT1 cells have the capacity to be considered as an alternative mean to manufacture cell-based flu vaccine, especially for the human strains (H1N1), due to its antigenic stability and high titer of influenza virus production compared to egg inoculation.Biography
Email: mehrbode@yahoo.com
